Latigo Biotherapeutics, Inc.
LTGO
Last
$16.00
Day
+8.2%
1y
—
5y
—
52w
—
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
—
EMA 50
—
EMA 200
—
20d high
—
5y high
—
5y range
—
Positions held
Your positionsLTGO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
—
Hold
—
Signal
—
Target
—
Stop
—
Stop distance
—
Target vs last
—
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
Bull case
- Latigo Biotherapeutics operates in the promising biotechnology sector, which is known for its potential to innovate and address unmet medical needs, attracting significant investor interest.
- Latigo Biotherapeutics has a market cap of approximately $1.08 billion, indicating a substantial valuation in the biotechnology space.
- The target mean price for LTGO is set at $52.25, suggesting a strong potential upside from its current trading levels.
Bear case
- The company has not generated any revenue, which raises concerns about its ability to sustain operations and attract further investment.
- Latigo Biotherapeutics reported a net income loss of -25.797 million in Q2 2026, continuing a trend of negative earnings over multiple quarters.
- The company has a high debt-to-equity ratio of 249.96, indicating significant leverage and potential financial risk.
Fundamentals
| Market cap | $980.57M | Enterprise value | $1.25B | Trailing P/E | — | Forward P/E | -7.08 |
| PEG | — | Price / book | -0.05 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 2.50 |
| Current ratio | 1.15 | Free cash flow | — | Analyst recommendation | none | Mean target | $52.25 |
| 52w high | $25.93 | 52w low | $14.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$25.8M | -$23.0M | -$25.8M | -$21.0M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$25.8M | -$23.4M | -$25.7M | -$21.5M |
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $0.0M | $0.0M |
| Op margin | — | — |
| Net income | -$109M | -$61.2M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$110M | -$63.5M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsNo price history yet for LTGO.
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin